Stockholders reject authorized share increase to 225M at ASMB annual meeting

ASSEMBLY BIOSCIENCES, INC.

All eight director nominees elected with no opposition.
Say-on-pay advisory approved (10.6M for, 1.7M against).
Ratification of Ernst & Young as auditor for FY2023 approved (21.5M for).
Amendment to 2018 Stock Incentive Plan increasing share reserve from 8.6M to 10.6M shares approved.
Proposal to increase authorized common stock from 150M to 225M shares failed, limiting future equity issuance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.